TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
239,987
|
245,136
|
244,644 |
| Financial expenses |
1,497
|
990
|
1,092 |
| Earnings before taxes |
18,577
|
15,070
|
17,084 |
| EBITDA |
19,617
|
16,161
|
18,318 |
| Total assets |
74,595
|
81,099
|
80,338 |
| Current assets |
73,076
|
79,501
|
78,590 |
| Current liabilities |
21,959
|
29,166
|
36,021 |
| Equity capital |
45,427
|
39,837
|
31,155 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
24
|
21
|
21 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
60.9%
|
49.1%
|
38.8% |
| Turnover per employee |
9,999
|
11,673
|
11,650 |
| Profit as a percentage of turnover |
7.7%
|
6.1%
|
7.0% |
| Return on assets (ROA) |
26.9%
|
19.8%
|
22.6% |
| Current ratio |
332.8%
|
272.6%
|
218.2% |
| Return on equity (ROE) |
40.9%
|
37.8%
|
54.8% |
| Change turnover |
-5,862
|
20,308
|
57,859 |
| Change turnover % |
-2%
|
9%
|
31% |
| Chg. No. of employees |
3
|
0
|
1 |
| Chg. No. of employees % |
14%
|
0%
|
5% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.